Paravaccine

Paravaccine is a new technology that is used to create vaccines against dangerous diseases. It is a hybrid between a vaccine and an antiviral drug that contains antibodies to the viral infection that help the body fight the virus. Paravaccines were first developed in 2016 by scientists from China, but have now become increasingly popular around the world.

Paravaccines are used to treat a variety of infectious diseases such as influenza, measles, mumps, rubella, hepatitis B and C, and other serious diseases including HIV. They combine the properties of the immune system and inhibitors, while maintaining the safety and effectiveness of drugs.

When creating paravaccines, a viral vaccine containing a small amount of virus in live form is used. The virus then interacts with antibodies to the virus